Klaus Münter

Title: Klaus Münter: Innovator in Pharmaceutical Combinations

Introduction

Klaus Münter is a notable inventor based in Mannheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of combined preparations for controlling diseases. With a total of 3 patents, his work has had a meaningful impact on medical treatments.

Latest Patents

Münter's latest patents include innovative combinations that enhance therapeutic efficacy. One of his notable inventions is the "Endothelin antagonist and beta receptor blocking agent as combined preparations." This patent describes a combination of endothelin antagonists and beta-receptor blockers, which is suitable for controlling various diseases. Another significant patent is the "Endothelin antagonist and renin-angiotensin system inhibitor as a combined preparation." This invention outlines a combination of endothelin antagonists and RAS inhibitors, also aimed at effectively managing diseases.

Career Highlights

Throughout his career, Klaus Münter has worked with prominent companies in the pharmaceutical industry. He has been associated with Abbott Laboratories Corporation and Knoll Aktiengesellschaft, where he contributed to various innovative projects. His expertise in pharmacology and drug development has been instrumental in advancing therapeutic options.

Collaborations

Münter has collaborated with several professionals in his field, including Michael Kirchengast and Horst Korioth. These collaborations have fostered a productive environment for innovation and have led to the successful development of his patented inventions.

Conclusion

Klaus Münter's contributions to the pharmaceutical industry through his innovative patents demonstrate his commitment to improving disease management. His work continues to influence the development of effective treatments in medicine.